Oxygen Biotherapeutics, Inc. (OXBT) announced the effectiveness of a 20-to-one reverse stock split of its common stock which was approved by the company's stockholders at a Special Meeting of Stockholders held on April 26, 2013, and was approved by the Company's Board of Directors on that same date.
The company said it has retained its transfer agent, Interwest Transfer Company, to act as its exchange agent for the reverse split. Interwest will provide shareholders of record as of the effective date a letter of transmittal providing instructions for the exchange of their certificates, if they wish to do so, however, an exchange is not required.
For comments and feedback: editorial@rttnews.com